NCT04547660View on ClinicalTrials.gov

Convalescent Plasma for Severe COVID-19 Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

January 7, 2021

Study Completion Date

January 7, 2021

Conditions
Covid19
Interventions
BIOLOGICAL

Convalescent Plasma

Fresh frozen plasma collected by apheresis from recovered COVID-19 patients added to best supportive care.

OTHER

Best Supportive Care

Any form of ventilatory support, extracorporeal membrane oxygenation, steroids, antibiotics and other supportive measures except for investigational interventions.

Trial Locations (1)

90035-903

Hospital de Clínicas de Porto Alegre, Porto Alegre

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil

OTHER

collaborator

Instituto Cultural Floresta

UNKNOWN

lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT04547660 - Convalescent Plasma for Severe COVID-19 Patients | Biotech Hunter | Biotech Hunter